Published in Antiviral Res on December 01, 1994
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety. Antimicrob Agents Chemother (1995) 0.79
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest (1998) 3.34
Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res (1997) 2.04
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol (1998) 1.79
Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2. Virology (1974) 1.74
Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharmacol (2000) 1.63
Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54
Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol (1999) 1.53
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins. Mol Pharmacol (1999) 1.52
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol (1999) 1.51
Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother (1996) 1.51
The cytoskeleton and related proteins in the human failing heart. Heart Fail Rev (2000) 1.49
The internal and external protein scaffold of the T-tubular system in cardiomyocytes. Cell Tissue Res (1998) 1.46
Imaging of chronic inflammatory bowel disease with 18F-FDG PET in children and adolescents. Klin Padiatr (2013) 1.46
Insertion mutations in the control region of the Gal operon of E. coli. I. Biological characterization of the mutations. Mol Gen Genet (1972) 1.44
Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol (1997) 1.37
Tryptic fingerprint analysis of adenovirus types 2, 5 and 12 DNA-Binding proteins. Virology (1976) 1.35
Adenovirus-infected, cell-specific, DNA-binding proteins. Cold Spring Harb Symp Quant Biol (1975) 1.34
Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med (1997) 1.31
P-glycoprotein-mediated secretion of a fluorescent cyclosporin analogue by teleost renal proximal tubules. Am J Physiol (1995) 1.30
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25
Early processes of echovirus 12-infection: elution, penetration, and uncoating under the influence of rhodanine. Virology (1979) 1.24
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
The relationship between group C adenovirus tumor antigen and the adenovirus single-strand DNA-binding protein. Cell (1976) 1.19
Injectable corticosteroid preparations: an embolic risk assessment by static and dynamic microscopic analysis. AJNR Am J Neuroradiol (2011) 1.18
Isolation and characterization of adenovirus type 12 DNA binding proteins. Virology (1975) 1.18
Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.15
Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J (1997) 1.13
Purification and partial characterization of poliovirus protease 2A by means of a functional assay. J Virol (1988) 1.13
alpha-Amanitin uptake into hepatocytes. Identification of hepatic membrane transport systems used by amatoxins. J Biol Chem (1986) 1.10
Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol (1994) 1.10
Extracorporeal microsurgical repair of injured multiple donor kidney arteries prior to cadaveric allotransplantation. Eur Urol (1985) 1.08
Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5'-triphosphate in comparison to cellular DNA polymerases alpha and beta. Biochem Biophys Res Commun (1987) 1.06
Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. Biochem Biophys Res Commun (1988) 1.04
p-Glycoprotein-mediated transport of a fluorescent rapamycin derivative in renal proximal tubule. J Pharmacol Exp Ther (1997) 1.04
An optimized assay of alanine aminopeptidase activity in urine. Clin Chem (1980) 1.03
Leucocidic substances for Aeromonas hydrophila. Zentralbl Bakteriol Orig A (1974) 1.02
Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res (1999) 1.01
Identity of hepatic membrane transport systems for bile salts, phalloidin, and antamanide by photoaffinity labeling. Proc Natl Acad Sci U S A (1984) 1.01
Helix-loop-helix motif in HIV-1 Rev. Biochemistry (1994) 1.00
2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity. J Med Chem (1987) 0.99
Isolation and characterization of the putative canalicular bile salt transport system of rat liver. J Biol Chem (1987) 0.99
Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest (1993) 0.98
New insights into mechanisms of atrial fibrillation. Physiol Res (2009) 0.98
Influenza pandemic: preparedness planning in Germany. Euro Surveill (2002) 0.98
Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol (1998) 0.97
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol (1994) 0.96
Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol (1996) 0.96
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology (1997) 0.96
IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur J Immunol (1994) 0.95
Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target (2000) 0.95
Double-blind study with thiazide in recurrent calcium lithiasis. J Urol (1982) 0.95
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun (1991) 0.95
Elevated levels of testosterone receptors in keloid tissue: an experimental investigation. Plast Reconstr Surg (1997) 0.94
Plasmodium vivax: in vitro antiparasitic effect of cyclosporins. Exp Parasitol (1996) 0.94
Altered balance between extracellular proteolysis and antiproteolysis is associated with adaptive coronary arteriogenesis. J Mol Cell Cardiol (2000) 0.94
The interleukin-17 gene of herpesvirus saimiri. J Virol (1998) 0.92
Ivermectin excretion by isolated functionally intact brain endothelial capillaries. Br J Pharmacol (2001) 0.92
Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents. J Med Chem (1992) 0.91
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates. Immunol Lett (1999) 0.90
Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease. J Urol (1984) 0.90
Biochemistry and pathogenicity of echovirus 9. I. Characterization of the virus particles of strains Barty and Hill. Virology (1982) 0.90
Multifaceted morphological alterations are present in the failing human heart. J Mol Cell Cardiol (1995) 0.89
Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov Disord (1993) 0.89
Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. J Steroid Biochem Mol Biol (2000) 0.88
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol (2000) 0.88
Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab Dispos (1999) 0.87
Quantification and visualization of the transport of octreotide, a somatostatin analogue, across monolayers of cerebrovascular endothelial cells. Pharm Res (1994) 0.87
Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether. Br J Pharmacol (1993) 0.87
Characterization of an adenovirus early protein required for viral DNA replication: a single strand specific DNA binding proteins. Mol Cell Biochem (1976) 0.86
Tissue-specific transcriptional activity of a pancreatic islet cell-specific enhancer sequence/Pax6-binding site determined in normal adult tissues in vivo using transgenic mice. Mol Endocrinol (1999) 0.86
Inhibition of HIV-replication by 3'-fluoro-modified nucleosides with low cytotoxicity. Biochem Biophys Res Commun (1989) 0.85
5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogue. J Med Chem (1985) 0.85
Somatostatin analogs--effects on gastric stress ulcerations in the rat. Results of a pilot study. Hepatogastroenterology (1981) 0.85
Biochemical markers in menopausal women. Scand J Clin Lab Invest Suppl (1997) 0.84
Urinary enzyme excretion by renal-transplant recipients in relation to interval after transplantation. Clin Chem (1982) 0.84
Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine. Eur J Pharm Sci (2000) 0.84
[Interactions between cardiomyocytes and extracellular matrix in the failing human heart]. Z Kardiol (1995) 0.84
Fluorescent derivatives of bile salts. III. Uptake of 7 beta-NBD-NCT into isolated hepatocytes by the transport systems for cholyltaurine. J Lipid Res (1993) 0.84
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J Exp Med (2001) 0.84
Uptake of phosphatidylserine-containing liposomes by liver sinusoidal endothelial cells in the serum-free perfused rat liver. Biochim Biophys Acta (2005) 0.84
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J Virol (1998) 0.84
Measurement of HIV-1 reverse transcriptase by a nonradioactive assay system. Ann N Y Acad Sci (1992) 0.83
The use of pediatric cadaver kidneys in renal transplantation (experience with 97 cases and comparison with adult kidneys). Int Urol Nephrol (1981) 0.83
Effect of bedtime ethanol on total inspiratory resistance and respiratory drive in normal nonsnoring men. Alcohol Clin Exp Res (1993) 0.83
P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. Br J Pharmacol (2000) 0.83
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity. Life Sci (1993) 0.83